↗ ResMed RMD Beats Estimates Consistently, Faces Market Volatility Amid Strong Growth and Undervaluation
ResMed Inc. (RMD) has consistently beaten estimates in its quarterly earnings for Q1, Q2, and Q3, despite a decrease in margins. The stock,...
7 months ago